User:Mr. Ibrahem/Regadenoson

Regadenoson, sold under the brand name Lexiscan among others, is a medication used for pharmacologic stress testing. It is used as part of radionuclide myocardial perfusion imaging. It is given by injection into a vein.

Common side effects include dizziness, headache, ST segment changes, flushing, shortness of breath, and chest pain. Other side effects may include seizures and anaphylaxis. It should not be used in people with low blood pressure or poorly controlled heart failure. It is an A2A adenosine receptor agonist which results in vasodilation of blood vessels to the heart.

Regadenoson was approved for medical use in the United States in 2008 and Europe in 2010. In the United States it costs about 270 USD per dose as of 2021.